結果ページ2 セクター：医療 産業：製薬会社（一般） 株式市場―見積もりと価格
価格、時価総額、PE、EPSを含む全株式と自己資本のリスト
すべての国
全取引所
- {{item.name}}
- 全取引所
- ASX (1)
- BSE (10)
- Budapest (1)
- Buenos Aires (13)
- Canadian Sec (1)
- Cboe CA (1)
- Frankfurt (45)
- Helsinki (2)
- HKSE (4)
- IOB (17)
- Istanbul (1)
- Jakarta (1)
- KSE (3)
- LSE (3)
- MCE (1)
- Mexico (14)
- Milan (5)
- Munich (1)
- NasdaqCM (1)
- NasdaqGM (1)
- NasdaqGS (6)
- NSE (10)
- NYSE (9)
- OTC Markets OTCPK (30)
- OTC Markets OTCQX (3)
- Paris (3)
- Santiago (4)
- São Paulo (14)
- SES (1)
- Shanghai (11)
- Shenzhen (11)
- Stockholm (3)
- Swiss (6)
- Taipei Exchange (1)
- Tokyo (9)
- Vienna (13)
- XETRA (12)
製薬会社（一般） (279)
| 名前 名前 | 価格 価格 |
24h% 7d chart 24h% & 7d |
時価総額 時価総額 | 出来高 出来高 | 過去24時間底値 | 過去24時間高値 | 時価総額 | PER (株価収益率) | 1株当たり利益 |
|---|
| 名前 名前 | 価格 価格 |
24h% 7d chart 24h% & 7d |
時価総額 時価総額 | 出来高 出来高 | 過去24時間底値 | 過去24時間高値 | 時価総額 | PER (株価収益率) | 1株当たり利益 | |
|---|---|---|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.pe }} | {{ item.eps }} {{ item.eps_usd }} | |
| Eli Lilly and Company LLY.SW | $675 768.01 USD |
0
|
$615.44B 700.24B USD | $42 47.79 USD | $780 887.47 USD | $780 887.47 USD | $615.44B 700.24B USD | 71.42 | $9.45 10.75 USD | |
| Johnson & Johnson JNJ.BA | $12,325 14.57 USD |
+0.61
|
$414.89T 490.42B USD | $3.59K 4.24 USD | $12,175 14.39 USD | $12,575 14.86 USD | $414.89T 490.42B USD | 6.21 | $1.98K 2.34 USD | |
| Johnson & Johnson JNJ.MX | $3,032 179.53 USD |
-1.81
|
$7.31T 432.64B USD | $3.26K 192.85 USD | $3,032 179.53 USD | $3,034.2 179.66 USD | $7.31T 432.64B USD | 17.19 | $176.32 10.44 USD | |
| Johnson & Johnson JNJB34.SA | $58.39 11.83 USD |
-0.63
|
$2.13T 430.92B USD | $3.28K 663.79 USD | $58 11.76 USD | $59.35 12.03 USD | $2.13T 430.92B USD | 17.02 | $3.43 0.7 USD | |
| AbbVie Inc. ABBV.BA | $21,675 25.62 USD |
+3.96
|
$359.13T 424.5B USD | $428 0.51 USD | $20,050 23.7 USD | $22,000 26 USD | $359.13T 424.5B USD | 8.22 | $2.64K 3.12 USD | |
| Johnson & Johnson JNJ.SN | $148.27 — |
0
|
$396.76B — | $0 — | $145.55 — | $145.55 — | $396.76B — | 22.43 | $6.61 — | |
| AbbVie Inc. ABBV34.SA | $63.78 12.93 USD |
+1.38
|
$1.82T 368.31B USD | $2.38K 482.79 USD | $62.91 12.75 USD | $64.14 13 USD | $1.82T 368.31B USD | 74.16 | $0.86 0.17 USD | |
| AbbVie Inc. ABBV.MX | $3,470 205.47 USD |
0
|
$6.15T 363.88B USD | $3 0.18 USD | $3,470 205.47 USD | $3,470 205.47 USD | $6.15T 363.88B USD | 74.06 | $46.85 2.77 USD | |
| Johnson & Johnson JNJ.F | $136.24 148.93 USD |
-0.87
|
$328.32B 358.9B USD | $1.11K 1.21K USD | $135.06 147.64 USD | $136.92 149.67 USD | $328.32B 358.9B USD | 17.20 | $7.92 8.66 USD | |
| Johnson & Johnson JNJ.VI | $135.98 148.64 USD |
-0.41
|
$328.02B 358.57B USD | $95 103.85 USD | $135.74 148.38 USD | $136.64 149.37 USD | $328.02B 358.57B USD | 17.16 | $7.92 8.66 USD | |
| AbbVie Inc. ABBV.VI | $158.2 172.93 USD |
+2.33
|
$282.36B 308.66B USD | $9 9.84 USD | $156.2 170.75 USD | $158.2 172.93 USD | $282.36B 308.66B USD | 76.42 | $2.07 2.26 USD | |
| AbbVie Inc. 4AB.DE | $158.4 173.15 USD |
+2.33
|
$282.35B 308.65B USD | $132 144.29 USD | $155.8 170.31 USD | $158.4 173.15 USD | $282.35B 308.65B USD | 75.07 | $2.11 2.31 USD | |
| AbbVie Inc. 4AB.F | $155.8 170.31 USD |
+0.65
|
$277.72B 303.58B USD | $20 21.86 USD | $155.4 169.87 USD | $155.8 170.31 USD | $277.72B 303.58B USD | 73.83 | $2.11 2.31 USD | |
| Novartis AG NVS.BA | $33,575 39.69 USD |
+3.79
|
$248.73T 294.01B USD | $20 0.02 USD | $33,575 39.69 USD | $33,575 39.69 USD | $248.73T 294.01B USD | 2.59 | $12.95K 15.31 USD | |
| Roche Holding AG ROGN.MX | $6,233.57 369.1 USD |
0
|
$4.92T 291.34B USD | $70 4.14 USD | $6,233.57 369.1 USD | $6,233.57 369.1 USD | $4.92T 291.34B USD | 25.44 | $244.98 14.51 USD | |
| Merck & Co., Inc. MRK.PA | $101.4 110.84 USD |
0
|
$260.61B 284.88B USD | $250 273.28 USD | $100.2 109.53 USD | $101.6 111.06 USD | $260.61B 284.88B USD | 21.03 | $4.82 5.27 USD | |
| AstraZeneca PLC AZN.BA | $41,375 48.91 USD |
+2.03
|
$239.93T 283.61B USD | $255 0.3 USD | $41,300 48.82 USD | $42,150 49.82 USD | $239.93T 283.61B USD | 8.33 | $4.96K 5.87 USD | |
| Novartis AG NVSN.MX | $2,235 132.34 USD |
0
|
$4.41T 261.38B USD | $2 0.12 USD | $2,235 132.34 USD | $2,235 132.34 USD | $4.41T 261.38B USD | 19.41 | $115.1 6.82 USD | |
| Merck & Co., Inc. MRK.BA | $18,850 22.28 USD |
+1.07
|
$220.9T 261.11B USD | $383 0.45 USD | $18,625 22.02 USD | $19,825 23.43 USD | $220.9T 261.11B USD | 0.25 | $74.34K 87.88 USD | |
| Roche Holding AG RHHVF | $316.83 — |
+1.22
|
$253.75B — | $16 — | $314.25 — | $316.83 — | $253.75B — | 24.86 | $12.74 — | |
| Novartis AG N1VS34.SA | $63.21 12.81 USD |
-2.08
|
$1.25T 253.04B USD | $211 42.77 USD | $63.21 12.81 USD | $63.66 12.9 USD | $1.25T 253.04B USD | 18.81 | $3.36 0.68 USD | |
| Roche Holding AG RHHBF | $332.48 — |
0
|
$250.76B — | $6 — | $296 — | $296 — | $250.76B — | 26.11 | $12.73 — | |
| AstraZeneca PLC A1ZN34.SA | $65.36 13.25 USD |
+0.35
|
$1.22T 248.16B USD | $95 19.25 USD | $65.31 13.24 USD | $65.79 13.33 USD | $1.22T 248.16B USD | 30.39 | $2.15 0.44 USD | |
| AstraZeneca PLC AZNN.MX | $1,350.39 79.96 USD |
0
|
$4.19T 247.9B USD | $1K 59.21 USD | $1,350.39 79.96 USD | $1,350.39 79.96 USD | $4.19T 247.9B USD | 30.57 | $44.16 2.61 USD | |
| Roche Holding AG RHO6.F | $34.57 37.78 USD |
-1.41
|
$217.81B 238.09B USD | $28 30.61 USD | $33.7 36.83 USD | $34.57 37.78 USD | $217.81B 238.09B USD | 25.22 | $1.37 1.5 USD | |
| Pfizer Inc. PFE.ST | $422.6 41.25 USD |
0
|
$2.42T 235.74B USD | $0 0 USD | $0 0 USD | $0 0 USD | $2.42T 235.74B USD | 0 | $0 0 USD | |
| Merck & Co., Inc. MRK.MX | $1,540 91.19 USD |
-0.07
|
$3.89T 230.05B USD | $9.14K 541.02 USD | $1,503 89 USD | $1,540 91.19 USD | $3.89T 230.05B USD | 11.64 | $132.22 7.83 USD | |
| Merck & Co., Inc. MRCK34.SA | $55.84 11.32 USD |
+0.09
|
$1.13T 230.04B USD | $3.06K 620.21 USD | $54.05 10.96 USD | $56.94 11.54 USD | $1.13T 230.04B USD | 11.58 | $4.82 0.98 USD | |
| AstraZeneca PLC AZNCF | $135.75 — |
0
|
$210.44B — | $200 — | $128.91 — | $129.25 — | $210.44B — | 30.23 | $4.49 — | |
| AstraZeneca PLC ZEGA.F | $60.5 66.13 USD |
+1.68
|
$190.98B 208.77B USD | $208 227.37 USD | $60.5 66.13 USD | $60.5 66.13 USD | $190.98B 208.77B USD | 30.55 | $1.98 2.16 USD | |
| AstraZeneca PLC ZEG.F | $121.75 133.09 USD |
-1.1
|
$188.73B 206.31B USD | $185 202.23 USD | $121.45 132.76 USD | $121.75 133.09 USD | $188.73B 206.31B USD | 30.74 | $3.96 4.33 USD | |
| Novartis AG NOTA.F | $94.8 103.63 USD |
-2.87
|
$187.24B 204.68B USD | $14 15.3 USD | $94.8 103.63 USD | $94.8 103.63 USD | $187.24B 204.68B USD | 18.33 | $5.17 5.65 USD | |
| Merck & Co., Inc. MRK.SN | $79.01 — |
+3.07
|
$204.21B — | $0 — | $79.01 — | $79.01 — | $204.21B — | 11.72 | $6.74 — | |
| Amgen Inc. AMGN.BA | $11,325 13.39 USD |
+3.66
|
$170.84T 201.94B USD | $120 0.14 USD | $11,250 13.3 USD | $11,350 13.42 USD | $170.84T 201.94B USD | 0.27 | $41.69K 49.28 USD | |
| Merck & Co., Inc. 6MK.F | $68.7 75.1 USD |
-1.43
|
$172.88B 188.98B USD | $317 346.52 USD | $67.4 73.68 USD | $69.9 76.41 USD | $172.88B 188.98B USD | 11.56 | $5.94 6.49 USD | |
| Merck & Co., Inc. MRK.VI | $68.7 75.1 USD |
-1.29
|
$172.88B 188.98B USD | $585 639.48 USD | $68.2 74.55 USD | $70.1 76.63 USD | $172.88B 188.98B USD | 11.74 | $5.85 6.39 USD | |
| Gilead Sciences, Inc. GILD.BA | $32,000 37.83 USD |
+1.75
|
$148.84T 175.93B USD | $42 0.05 USD | $32,000 37.83 USD | $32,650 38.59 USD | $148.84T 175.93B USD | 76.50 | $418.28 0.49 USD | |
| Amgen Inc. AMGN.MX | $5,500 325.67 USD |
0
|
$2.95T 174.95B USD | $0 0 USD | $5,500 325.67 USD | $5,500 325.67 USD | $2.95T 174.95B USD | 37.03 | $148.5 8.79 USD | |
| Amgen Inc. AMGN34.SA | $56.5 11.45 USD |
+0.04
|
$855.38B 173.37B USD | $4 0.81 USD | $56.5 11.45 USD | $56.52 11.46 USD | $855.38B 173.37B USD | 36.45 | $1.55 0.31 USD | |
| Pfizer Inc. PFE.BA | $6,800 8.04 USD |
+2.72
|
$143.87T 170.06B USD | $3.78K 4.47 USD | $6,600 7.8 USD | $6,950 8.22 USD | $143.87T 170.06B USD | 2.18 | $3.11K 3.68 USD | |
| Gilead Sciences, Inc. GILD34.SA | $304.12 61.64 USD |
+0.77
|
$764.79B 155.01B USD | $120 24.32 USD | $304.12 61.64 USD | $304.12 61.64 USD | $764.79B 155.01B USD | 279.00 | $1.09 0.22 USD | |
| Gilead Sciences, Inc. GILD.MX | $1,971.21 116.72 USD |
0
|
$2.6T 154.08B USD | $0 0 USD | $1,971.21 116.72 USD | $1,971.21 116.72 USD | $2.6T 154.08B USD | 263.17 | $7.49 0.44 USD | |
| Pfizer Inc. PFIZ34.SA | $32.44 6.58 USD |
+2.01
|
$741.34B 150.26B USD | $1K 202.68 USD | $31.59 6.4 USD | $32.44 6.58 USD | $741.34B 150.26B USD | 16.05 | $2.02 0.41 USD | |
| Pfizer Inc. PFE.MX | $446.5 26.44 USD |
+1.49
|
$2.53T 149.94B USD | $53 3.14 USD | $438.7 25.98 USD | $446.5 26.44 USD | $2.53T 149.94B USD | 16.13 | $27.67 1.64 USD | |
| Pfizer Inc. PFE.SN | $26.06 — |
0
|
$147.8B — | $0 — | $26.06 — | $26.06 — | $147.8B — | 18.48 | $1.41 — | |
| Amgen Inc. AMG.DE | $246.9 269.9 USD |
+0.24
|
$132.64B 144.99B USD | $157 171.62 USD | $242.75 265.36 USD | $246.95 269.95 USD | $132.64B 144.99B USD | 37.12 | $6.65 7.27 USD | |
| Amgen Inc. AMGN.VI | $246.9 269.9 USD |
+0.35
|
$132.64B 144.99B USD | $75 81.99 USD | $241.65 264.16 USD | $247.95 271.04 USD | $132.64B 144.99B USD | 37.57 | $6.57 7.18 USD | |
| Amgen Inc. AMG.F | $245 267.82 USD |
+0.41
|
$132.18B 144.49B USD | $17 18.58 USD | $244 266.72 USD | $245 267.82 USD | $132.18B 144.49B USD | 36.78 | $6.66 7.28 USD | |
| Gilead Sciences, Inc. GILD.SN | $95.78 — |
+6.77
|
$141.59B — | $0 — | $95.78 — | $95.78 — | $141.59B — | 252.05 | $0.38 — | |
| Sanofi SANF.MI | $96.82 105.84 USD |
0
|
$121.24B 132.54B USD | $0 0 USD | $0 0 USD | $0 0 USD | $121.24B 132.54B USD | 0 | $0 0 USD | |
| Bristol-Myers Squibb Company BMY.BA | $19,575 23.14 USD |
+2.35
|
$111.48T 131.78B USD | $108 0.13 USD | $19,400 22.93 USD | $19,650 23.23 USD | $111.48T 131.78B USD | 0 | -$4,863 -5.7 USD | |
| Pfizer Inc. PFEB.F | $6.85 7.49 USD |
+7.03
|
$119.74B 130.89B USD | $178 194.58 USD | $6.25 6.83 USD | $6.85 7.49 USD | $119.74B 130.89B USD | 16.30 | $0.42 0.46 USD | |
| Gilead Sciences, Inc. GILD.VI | $94.46 103.26 USD |
+1.79
|
$118.93B 130B USD | $10 10.93 USD | $93.21 101.89 USD | $94.46 103.26 USD | $118.93B 130B USD | 286.24 | $0.33 0.36 USD | |
| Sanofi SNYNF | $106.45 — |
0
|
$129.99B — | $160 — | $103.98 — | $105.84 — | $129.99B — | 21.03 | $5.06 — | |
| Gilead Sciences, Inc. GIS.DE | $94.56 103.37 USD |
+1.74
|
$118.88B 129.95B USD | $693 757.54 USD | $93.25 101.93 USD | $94.71 103.53 USD | $118.88B 129.95B USD | 286.54 | $0.33 0.36 USD | |
| Gilead Sciences, Inc. GIS.F | $93.51 102.22 USD |
+0.73
|
$117.69B 128.66B USD | $35 38.26 USD | $93.51 102.22 USD | $93.51 102.22 USD | $117.69B 128.66B USD | 283.36 | $0.33 0.36 USD | |
| Sanofi SNW.F | $94 102.75 USD |
+0.91
|
$114.79B 125.48B USD | $1.04K 1.14K USD | $92.18 100.77 USD | $95.5 104.39 USD | $114.79B 125.48B USD | 21.41 | $4.39 4.8 USD | |
| Sanofi SANO.VI | $93.25 101.93 USD |
+0.13
|
$113.87B 124.48B USD | $249 272.19 USD | $92.2 100.79 USD | $93.42 102.12 USD | $113.87B 124.48B USD | 21.24 | $4.39 4.8 USD | |
| Pfizer Inc. PFE.VI | $20.03 21.89 USD |
+0.18
|
$113.57B 124.15B USD | $3.16K 3.46K USD | $19.61 21.44 USD | $20.08 21.95 USD | $113.57B 124.15B USD | 16.28 | $1.23 1.34 USD | |
| Sanofi SNW2.F | $45.8 50.07 USD |
-0.87
|
$111.86B 122.28B USD | $100 109.31 USD | $45.8 50.07 USD | $46.6 50.94 USD | $111.86B 122.28B USD | 20.91 | $2.19 2.39 USD | |
| Bristol-Myers Squibb Company BMYB34.SA | $268 54.32 USD |
-2.36
|
$551.8B 111.84B USD | $50 10.13 USD | $268 54.32 USD | $272.25 55.18 USD | $551.8B 111.84B USD | 0 | -$25.25 -5.1 USD | |
| Bristol-Myers Squibb Company BMY.MX | $925 54.77 USD |
-5.32
|
$1.88T 111.45B USD | $11 0.65 USD | $925 54.77 USD | $925 54.77 USD | $1.88T 111.45B USD | 0 | -$86.56 -5.1 USD | |
| GSK plc GSK.BA | $11,325 13.39 USD |
+2.95
|
$91.75T 108.45B USD | $10 0.01 USD | $11,225 13.27 USD | $11,325 13.39 USD | $91.75T 108.45B USD | 24.86 | $455.4 0.54 USD | |
| Gilead Sciences, Inc. GILD.MI | $72.4 79.14 USD |
0
|
$90.19B 98.59B USD | $0 0 USD | $0 0 USD | $0 0 USD | $90.19B 98.59B USD | 0 | $0 0 USD | |
| Bristol-Myers Squibb Company BRM.DE | $42.6 46.57 USD |
+0.73
|
$87.64B 95.8B USD | $1.43K 1.57K USD | $41.68 45.56 USD | $43.42 47.46 USD | $87.64B 95.8B USD | 0 | -$3.89 -4.2 USD | |
| Bristol-Myers Squibb Company BMYS.VI | $42.61 46.58 USD |
+0.61
|
$87.53B 95.68B USD | $137 149.76 USD | $41.42 45.27 USD | $42.79 46.78 USD | $87.53B 95.68B USD | 0 | -$3.83 -4.1 USD | |
| Bristol-Myers Squibb Company BRM.F | $42.57 46.53 USD |
-0.53
|
$86.62B 94.69B USD | $2.05K 2.24K USD | $42.17 46.09 USD | $42.57 46.53 USD | $86.62B 94.69B USD | 0 | -$3.89 -4.2 USD | |
| Chugai Pharmaceutical Co., Ltd. CUP.F | $50.4 55.09 USD |
-0.79
|
$82.93B 90.66B USD | $688 752.08 USD | $50.22 54.9 USD | $50.4 55.09 USD | $82.93B 90.66B USD | 34.75 | $1.45 1.59 USD | |
| GSK plc G1SK34.SA | $42.28 8.57 USD |
0
|
$428.14B 86.78B USD | $0 0 USD | $42.28 8.57 USD | $42.28 8.57 USD | $428.14B 86.78B USD | 22.37 | $1.89 0.38 USD | |
| GSK plc GSKN.MX | $711 42.1 USD |
0
|
$1.45T 86.13B USD | $2 0.12 USD | $711 42.1 USD | $711 42.1 USD | $1.45T 86.13B USD | 21.93 | $32.42 1.92 USD | |
| GSK GLAXF | $18.46 — |
+6.58
|
$74.77B — | $12 — | $18.46 — | $18.46 — | $74.77B — | 22.24 | $0.83 — | |
| Bayer Aktiengesellschaft BAY.MI | $55.5 60.67 USD |
0
|
$55.21B 60.36B USD | $0 0 USD | $0 0 USD | $0 0 USD | $55.21B 60.36B USD | 0 | $0 0 USD | |
| Daiichi Sankyo Company, Limited D4S.F | $20.79 22.73 USD |
+3.38
|
$39.22B 42.87B USD | $50 54.66 USD | $20.22 22.1 USD | $20.79 22.73 USD | $39.22B 42.87B USD | 25.98 | $0.8 0.87 USD | |
| Bayer Aktiengesellschaft BAYER.BD | $9,114 25.21 USD |
+0.57
|
$8.95T 24.76B USD | $108 0.3 USD | $9,033 24.98 USD | $9,114 25.21 USD | $8.95T 24.76B USD | 0 | -$1,060.2 -2.9 USD | |
| Biogen Inc. BIIB.MX | $2,854 168.99 USD |
0
|
$417.75B 24.74B USD | $0 0 USD | $2,854 168.99 USD | $2,854 168.99 USD | $417.75B 24.74B USD | 13.00 | $219.47 13 USD | |
| Bayer Aktiengesellschaft BAYN.VI | $22.54 24.63 USD |
+2.04
|
$22.16B 24.22B USD | $0 0 USD | $22.23 24.3 USD | $22.54 24.63 USD | $22.16B 24.22B USD | 0 | -$2.6 -2.8 USD | |
| Otsuka Holdings Co., Ltd. OS1.F | $40.8 44.6 USD |
-0.49
|
$21.81B 23.84B USD | $19 20.77 USD | $40.8 44.6 USD | $40.8 44.6 USD | $21.81B 23.84B USD | 10.43 | $3.91 4.27 USD | |
| Biogen Inc. BIIB.BA | $11,050 13.06 USD |
+2.31
|
$19.52T 23.07B USD | $172 0.2 USD | $10,925 12.91 USD | $11,225 13.27 USD | $19.52T 23.07B USD | 0.89 | $12.33K 14.58 USD | |
| Bayer Aktiengesellschaft BAYA.F | $5.3 5.79 USD |
-4.5
|
$20.83B 22.77B USD | $150 163.97 USD | $5.3 5.79 USD | $5.3 5.79 USD | $20.83B 22.77B USD | 0 | -$0.65 -0.7 USD | |
| Biogen Inc. BIIB34.SA | $113.96 23.1 USD |
0
|
$100.49B 20.37B USD | $0 0 USD | $113.96 23.1 USD | $113.96 23.1 USD | $100.49B 20.37B USD | 10.73 | $10.62 2.15 USD | |
| Astellas Pharma ALPMF | $8.87 — |
0
|
$17.16B — | $1.3K — | $8.99 — | $8.99 — | $17.16B — | 0 | -$0.23 — | |
| Astellas Pharma Inc. YPHA.F | $8.4 9.18 USD |
+3.7
|
$15.68B 17.14B USD | $1.2K 1.31K USD | $8.1 8.85 USD | $8.4 9.18 USD | $15.68B 17.14B USD | 0 | -$0.2 -0.2 USD | |
| Biogen Inc. IDP.DE | $105.5 115.33 USD |
+1.49
|
$15.47B 16.91B USD | $203 221.91 USD | $104 113.69 USD | $105.5 115.33 USD | $15.47B 16.91B USD | 10.71 | $9.85 10.77 USD | |
| Biogen Inc. BIIB.VI | $105.35 115.16 USD |
+1.2
|
$15.42B 16.86B USD | $312 341.06 USD | $103.9 113.58 USD | $105.35 115.16 USD | $15.42B 16.86B USD | 10.84 | $9.71 10.61 USD | |
| Biogen Inc. IDP.F | $103.55 113.19 USD |
-1.52
|
$15.16B 16.57B USD | $50 54.66 USD | $103.2 112.81 USD | $103.6 113.25 USD | $15.16B 16.57B USD | 10.51 | $9.85 10.77 USD | |
| Astellas Pharma Inc. YPH.F | $8.22 8.99 USD |
-2
|
$14.81B 16.19B USD | $80 87.45 USD | $8.22 8.99 USD | $8.22 8.99 USD | $14.81B 16.19B USD | 0 | -$0.2 -0.2 USD | |
| Cipla Limited CIPLA.BO | $1,551.3 18.77 USD |
+1.16
|
$1.25T 15.16B USD | $20.69K 250.34 USD | $1,525.25 18.45 USD | $1,556 18.83 USD | $1.25T 15.16B USD | 25.10 | $61.8 0.75 USD | |
| Recordati Industria Chimica e Farmaceutica S.p.A. RER1.F | $49.32 53.91 USD |
+1.69
|
$10.26B 11.22B USD | $40 43.73 USD | $48.62 53.15 USD | $49.32 53.91 USD | $10.26B 11.22B USD | 24.78 | $1.99 2.18 USD | |
| Recordati Industria Chimica e Farmaceutica S.p.A. REC.VI | $49.48 54.09 USD |
+1.52
|
$10.24B 11.2B USD | $0 0 USD | $48.9 53.45 USD | $49.48 54.09 USD | $10.24B 11.2B USD | 24.86 | $1.99 2.18 USD | |
| CSPC Pharmaceutical CHJTF | $0.64 — |
0
|
$9.05B — | $20K — | $0.6199 — | $0.6199 — | $9.05B — | 12.79 | $0.05 — | |
| CSPC Pharmaceutical Group Limited CVGU.F | $2.54 2.78 USD |
-1.55
|
$7.85B 8.58B USD | $250 273.28 USD | $2.54 2.78 USD | $2.54 2.78 USD | $7.85B 8.58B USD | 14.11 | $0.18 0.2 USD | |
| CSPC Pharmaceutical Group Limited CVG.F | $0.67 0.73 USD |
-1.85
|
$7.83B 8.56B USD | $32.79K 35.84K USD | $0.67 0.73 USD | $0.67 0.73 USD | $7.83B 8.56B USD | 16.72 | $0.04 0.04 USD | |
| Kyowa Kirin KYKOF | $14.75 — |
0
|
$8.11B — | $316 — | $14.75 — | $14.75 — | $8.11B — | 18.43 | $0.8 — | |
| Orion Oyj OFK0.F | $25.2 27.55 USD |
+5
|
$7.4B 8.09B USD | $0 0 USD | $25.2 27.55 USD | $25.2 27.55 USD | $7.4B 8.09B USD | 20.32 | $1.24 1.36 USD | |
| Orion Oyj ORINY | $28.25 — |
0
|
$8B — | $101 — | $26.31 — | $26.31 — | $8B — | 19.75 | $1.43 — | |
| Orion Oyj OFK.F | $50.05 54.71 USD |
+1.27
|
$7.14B 7.8B USD | $1 1.09 USD | $50.05 54.71 USD | $50.05 54.71 USD | $7.14B 7.8B USD | 20.18 | $2.48 2.71 USD | |
| Kyowa Kirin Co., Ltd. KY4.F | $13.4 14.65 USD |
-0.74
|
$7.09B 7.76B USD | $254 277.66 USD | $13.4 14.65 USD | $13.5 14.76 USD | $7.09B 7.76B USD | 19.14 | $0.7 0.77 USD | |
| Abbott India Limited ABBOTINDIA.NS | $30,060 363.68 USD |
-1.35
|
$638.75B 7.73B USD | $6.81K 82.35 USD | $30,010 363.07 USD | $30,680 371.18 USD | $638.75B 7.73B USD | 47.89 | $627.68 7.59 USD | |
| Abbott India Limited ABBOTINDIA.BO | $30,028.45 363.29 USD |
-1.35
|
$638.08B 7.72B USD | $250 3.02 USD | $30,005 363.01 USD | $30,470 368.64 USD | $638.08B 7.72B USD | 47.88 | $627.03 7.59 USD | |
| Orion Oyj ORINF | $48.65 — |
0
|
$7.63B — | $43 — | $47.16 — | $47.16 — | $7.63B — | 19.69 | $2.47 — | |
|
お気に入り銘柄なし
お気に入りの株式はまだありません。ここで表示するにはお気に入りに追加してください |
||||||||||
- {{ link.label }} {{link}}